A5023685265- Glaucoma and retinal disorders
- Ocular Surface and Contact Lens
- Antioxidant Activity and Oxidative Stress
- Corneal surgery and disorders
- Corneal Surgery and Treatments
- Reconstructive Facial Surgery Techniques
- Retinal Diseases and Treatments
- Neurological Disorders and Treatments
- Biochemical Acid Research Studies
- Facial Rejuvenation and Surgery Techniques
- Inflammasome and immune disorders
- Ocular Infections and Treatments
- Heme Oxygenase-1 and Carbon Monoxide
- Retinoids in leukemia and cellular processes
- Fatty Acid Research and Health
- Facial Nerve Paralysis Treatment and Research
- Birth, Development, and Health
- Medicinal Plants and Bioactive Compounds
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Ocular Disorders and Treatments
- Ocular Oncology and Treatments
- Natural Antidiabetic Agents Studies
- Dermatologic Treatments and Research
- Advanced Glycation End Products research
Hospital de Manises
2020-2022
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2017-2020
Universitat de València
2017-2020
Glaucoma has no cure and is a sight-threatening neurodegenerative disease affecting more than 100 million people worldwide, with primary open angle glaucoma (POAG) being the most globally prevalent clinical type. Regulation of gene expression networks, its multifactorial pathways involved in are landmarks for ophthalmic research. MicroRNAs (miRNAs/miRs) small endogenous non-coding, single-stranded RNA molecules (18–22 nucleotides) that regulate expression. An analytical, observational,...
Macular pigment optical density (MPOD) plays a pivotal role in maintaining macular structure and functioning. Research shows that daily consumption of lutein reduces the risk eye diseases such as age-related degeneration.This study analyzes influence supplementation containing antioxidant vitamins either with or without docosahexaenoic acid (DHA), main objective identifying MPOD changes both eyes at end follow-up using Visucam®retinograph. The secondary point was to determine variation DHA...
To evaluate skin biocompatibility of a nighttime hydrating eyelid gel and possible ocular surface effects in contact lens users (CLU) non-contact (NCLU). The formulation is registered as medical device Tridocosahexaenoine-AOX® (TDHA-AOX) (a concentrated DHA triglyceride), containing also hyaluronic acid (HA). A prospective, randomized, masked clinical trial was performed with 62 participants both sexes, aged 20–70 years, split into: (1) CLU (n = 30) (2) NCLU 32). All were instructed to apply...
ResumenLa técnica
Abstract Purpose: To describe the microRNAs (miRNAs) involved in ocular hypertension (OHT) and open‐angle glaucoma (OAG) to develop miRNA‐based diagnostic therapeutic tools. Methods: An analytical, observational, case–control study was performed 42 volunteers of both sexes, aged 50 80 years, that were classified according to: suffering OHT ( n = 20) or with diagnosis OAG 20). All participants interviewed for obtaining sociodemographic personal/familial records, ophthalmologically examined,...